UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050905
Receipt number R000058018
Scientific Title The Prevalence of Pre-Diabetes in SARS-Cov-2 positivity in COVID-19 pandemic.
Date of disclosure of the study information 2023/04/24
Last modified on 2023/04/22 16:26:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of COVID-19 infection

Acronym

Study of COVID-19 infection

Scientific Title

The Prevalence of Pre-Diabetes in SARS-Cov-2 positivity in COVID-19 pandemic.

Scientific Title:Acronym

Study of SARS-Cov-2 positivity

Region

Japan


Condition

Condition

Impaired glucose tolerance

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Prevention

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Methods of infection control for COVID-19

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Men and woman between 20 and 100 years old

Key exclusion criteria

None

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Saito

Organization

Toho University Graduate School of Medicine

Division name

Division of Diabetes Metabolism and Endocrinology Department of Internal Medicine

Zip code

143-8541

Address

6-11-1 Omori-nishi, Ota-ku Tokyo

TEL

03-3762-4151

Email

Manabu.saitou@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Uchino

Organization

Toho University Graduate School of Medicine

Division name

Division of Diabetes Metabolism and Endocrinology Department of Internal Medicine

Zip code

143-8541

Address

6-11-1 Omori-nishi, Ota-ku Tokyo

TEL

03-3762-4151

Homepage URL


Email

h.uchino@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board of Toho University Medical Center Omori Hospital

Address

6-11-1 Omori-nishi, Ota-ku Tokyo

Tel

03-3762-4151

Email

omori.rinri@ext.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

54

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 19 Day

Date of IRB

2020 Year 09 Month 10 Day

Anticipated trial start date

2020 Year 09 Month 11 Day

Last follow-up date

2023 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a retrospective observational cohort study.Patients diagnosed as COVID-19 as testing by PCR at Toho University Medical Center Omori Hospital from February 2020 to May 2020.


Management information

Registered date

2023 Year 04 Month 22 Day

Last modified on

2023 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058018


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name